For the Inventor, By the Inventor

Enter assignee name

Stockholm, Sweden

Swedish Orphan Biovitrum Ab (Publ)

USPTO Granted Patents = 14

Trademarks = 19

Forward Citations = 17

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Jonas Fransson (5 out of 7 patents)

Patrik Strömberg (4 out of 9 patents)

Erik Nordling (4 out of 7 patents)

4. Ebba Florin-Robertsson (3 out of 11 patents)

5. Charlotta Berghard (3 out of 5 patents)

6. Joachim Feldwisch (3 out of 15 patents)

7. Malin Lindborg (3 out of 10 patents)

8. Joakim Nilsson (3 out of 5 patents)

9. Elin Gunneriusson (2 out of 19 patents)

10. Magnus Berglund (2 out of 4 patents)

11. Stefan Svensson Gelius (2 out of 2 patents)

12. Pelle Reinius (1 out of 1 patent)

13. Bruce A Kerwin (1 out of 10 patents)

14. Andrei Raibekas (1 out of 2 patents)

15. Agneta Tjernberg (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12116397 - IL-IR-I binding polypeptide (2024-10-15),

2. 11730677 - Syringe assembly with ion-exchange material (2023-08-22),

3. 11584778 - Fusion protein with half-life extending polypeptide (2023-02-21),

4. 11324807 - Compositions comprising anakinra (2022-05-10),

5. 11191903 - Syringe plunger rod (2021-12-07),

6. 10765747 - Methods of reducing aggregation of IL-1ra (2020-09-08),

7. 10206975 - Polypeptides binding to human complement C5 (2019-02-19),

8. 10179162 - Citrate free pharmaceutical compositions comprising anakinra (2019-01-15),

9. 9994626 - Stable polypeptides binding to human complement C5 (2018-06-12),

10. 9982243 - Modified sulfamidase and production thereof (2018-05-29),

11. 9808502 - Polypeptides binding to human complement C5 (2017-11-07),

12. 9198954 - Citrate free pharmaceutical compositions comprising anakinra (2015-12-01),

13. 8986682 - Method to increase the absorption of unsaturated fatty acids by human infants (2015-03-24),

14. 8304387 - Therapeutic formulations of keratinocyte growth factor (2012-11-06),

Swedish Orphan Biovitrum AB (publ) (Sobi) is a biopharmaceutical company focused on rare diseases. They develop and deliver innovative therapies and services to improve the lives of patients worldwide. Sobi specializes in treatments for hemophilia, autoimmune diseases, and other rare conditions. With a mission to make a meaningful difference for patients, Sobi works collaboratively with healthcare professionals, patients, and organizations to advance medical research and raise awareness about rare diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#59 in Stockholm

#422 in Sweden

#40,929 in the World

Stockholm, Sweden

Swedish Orphan Biovitrum Ab (Publ)

Forward Citations = 17

28 inventors:

Jonas Fransson (5 out of 7 patents)

Patrik Strömberg (4 out of 9 patents)

Erik Nordling (4 out of 7 patents)

4. Ebba Florin-Robertsson (3 out of 11 patents)

5. Charlotta Berghard (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…